Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
BiomX Inc has a consensus price target of $6.5 based on the ratings of 3 analysts. The high is $15 issued by HC Wainwright & Co. on May 16, 2025. The low is $2 issued by Chardan Capital on November 10, 2022. The 3 most-recent analyst ratings were released by HC Wainwright & Co. on May 16, 2025, April 4, 2025, and April 1, 2025, respectively. With an average price target of $19 between HC Wainwright & Co., there's an implied 4073.99% upside for BiomX Inc from these most-recent analyst ratings.
1calculated from analyst ratings
Buy Now | Get Alert | |||||||
---|---|---|---|---|---|---|---|---|
05/16/2025 | Buy Now | 3195.25% | HC Wainwright & Co. | Joseph Pantginis46% | $21 → $15 | Maintains | Buy | Get Alert |
04/04/2025 | Buy Now | 4513.36% | HC Wainwright & Co. | Joseph Pantginis46% | $21 → $21 | Reiterates | Buy → Buy | Get Alert |
04/01/2025 | Buy Now | 4513.36% | HC Wainwright & Co. | Joseph Pantginis46% | $2 → $21 | Maintains | Buy | Get Alert |
01/10/2025 | Buy Now | 339.37% | HC Wainwright & Co. | Joseph Pantginis46% | $2 → $2 | Reiterates | Buy → Buy | Get Alert |
01/08/2025 | Buy Now | 339.37% | HC Wainwright & Co. | Joseph Pantginis46% | $2 → $2 | Maintains | Buy | Get Alert |
08/16/2024 | Buy Now | 339.37% | HC Wainwright & Co. | Joseph Pantginis46% | $2 → $2 | Reiterates | Buy → Buy | Get Alert |
05/28/2024 | Buy Now | 449.21% | Laidlaw & Co. | Yale Jen22% | → $2.5 | Initiates | → Buy | Get Alert |
05/21/2024 | Buy Now | 339.37% | HC Wainwright & Co. | Joseph Pantginis46% | $2 → $2 | Reiterates | Buy → Buy | Get Alert |
04/22/2024 | Buy Now | 339.37% | HC Wainwright & Co. | Joseph Pantginis46% | $2 → $2 | Reiterates | Buy → Buy | Get Alert |
04/03/2024 | Buy Now | 339.37% | HC Wainwright & Co. | Joseph Pantginis46% | $2 → $2 | Reiterates | Buy → Buy | Get Alert |
03/07/2024 | Buy Now | 339.37% | HC Wainwright & Co. | Joseph Pantginis46% | $7 → $2 | Reiterates | Buy → Buy | Get Alert |
11/14/2023 | Buy Now | 1437.79% | HC Wainwright & Co. | Joseph Pantginis46% | → $7 | Reiterates | Buy → Buy | Get Alert |
08/09/2023 | Buy Now | 1437.79% | HC Wainwright & Co. | Joseph Pantginis46% | → $7 | Reiterates | → Buy | Get Alert |
05/15/2023 | Buy Now | 1437.79% | HC Wainwright & Co. | Joseph Pantginis46% | $10 → $7 | Maintains | Buy | Get Alert |
11/10/2022 | Buy Now | 339.37% | Chardan Capital | Keay Nakae56% | $6 → $2 | Maintains | Buy | Get Alert |
The latest price target for BiomX (AMEX:PHGE) was reported by HC Wainwright & Co. on May 16, 2025. The analyst firm set a price target for $15.00 expecting PHGE to fall to within 12 months (a possible NaN% downside). 6 analyst firms have reported ratings in the last year.
The latest analyst rating for BiomX (AMEX:PHGE) was provided by HC Wainwright & Co., and BiomX maintained their buy rating.
There is no last upgrade for BiomX
There is no last downgrade for BiomX.
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of BiomX, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for BiomX was filed on May 16, 2025 so you should expect the next rating to be made available sometime around May 16, 2026.
While ratings are subjective and will change, the latest BiomX (PHGE) rating was a maintained with a price target of $21.00 to $15.00. The current price BiomX (PHGE) is trading at is $undefined, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.
A newsletter built for market enthusiasts by market enthusiasts. Top stories, top movers, and trade ideas delivered to your inbox every weekday before and after the market closes.